Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002575 |
---|---|
Receipt number | R000003138 |
Scientific Title | A Double-Blind, Placebo-Controlled Study With 2-Docosahexaenoyl-3-Phosphatidylserine in Cognitive Disorder |
Date of disclosure of the study information | 2009/10/05 |
Last modified on | 2021/10/11 13:41:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/02 09:10:14 | ||
2 | Update | 2009/11/10 18:34:38 | Recruitment status |
|
3 | Update | 2010/04/05 16:54:27 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2010/04/05 16:57:04 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2010/10/04 10:14:57 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2011/10/10 23:28:11 | Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2011/10/10 23:31:24 | Results Results |
|
8 | Update | 2021/10/11 13:41:03 | Recruitment status Date of IRB |